Single vaccine could protect against all coughs, colds and flus

What this “vaccine” actually is

• Several commenters argue it’s not a classic vaccine but more like:
  • A nonspecific, prophylactic immune stimulant / “immunoinduction” via toll‑like receptors.
  • A “line of cocaine for macrophages” that boosts readiness, not antigen-specific memory.
• Some think stretching the word “vaccine” (like “vegan leather”) is misleading and may hurt adoption; others note the term has already broadened and might expand further to cover general immune boosters.

Evolution vs engineering the immune system

• One line of skepticism: if having lung macrophages on constant “alert” were good, evolution would already have done it; therefore long‑term risks (autoimmunity, cancer, energy cost) are likely.
• Counter‑arguments:
  • Evolution optimizes for “good enough to reproduce,” not for health or safety.
  • Many biological designs are obviously suboptimal (vision setup, spine, appendix, strange animal anatomies), so “don’t mess with evolution” is not compelling.
  • Still, the immune system is extremely complex and poorly understood, so tuning it is risky and drug failures show we often misjudge side effects.

Autoimmunity, allergies, and safety concerns

• Strong worry that chronic or repeated “high alert” could:
  • Trigger or worsen autoimmune disease.
  • Aggravate food allergies or other hypersensitivities.
• Others note:
  • The article itself flags “friendly fire” immune risks.
  • The experimental treatment seemed to reduce dust‑mite responses and targets lung macrophages specifically, which may constrain systemic effects.
• Some suggest an ideal use would be short‑lived priming (e.g., for flights or conferences) rather than continuous activation.

Trial design and who it helps

• Commenters expect early trials will use healthy subjects; people with autoimmune conditions or chronic illness will have to decide with little direct data.
• There is concern that respiratory diseases rarely kill during reproductive years, so evolution hasn’t strongly selected against them, but that doesn’t mean immune tuning is free of hidden costs.

“In mice” and translation to humans

• Multiple people stress that results are only in animals so far.
• Debate over mouse models:
  • Pro: mice are genetically very similar and share many diseases; success in mice is a major, necessary hurdle.
  • Con: decades of “breakthrough (in mice)” hype rarely reaching clinic fuel public cynicism; criticism is aimed at pop‑science marketing more than at the underlying genomics.